We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$9.79B
AUM Growth
+$1.37B
(+16%)
Cap. Flow
+$258M
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
15.58%
Holding
2,579
New
256
Increased
680
Reduced
638
Closed
183
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$31.5M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$20.5M |
| 3 |
THOR
THORATEC CORPORATION
THOR
|
+$13.5M |
| 4 |
eBay
EBAY
|
+$12.8M |
| 5 |
Korn Ferry
KFY
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$20.9M |
| 2 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$15.2M |
| 3 |
JPMorgan Chase
JPM
|
+$13.2M |
| 4 |
Pediatrix Medical
MD
|
+$12.5M |
| 5 |
Viatris
VTRS
|
+$9.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Industrials | 13.03% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 11.32% |
| 5 | Energy | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Vertex Pharmaceuticals
VRTX
$123B
| $1.96M | 0.02% |
26,327
+25,423
| +2,812% | +$1.77M |
|
|
BWP
527
DELISTED
Boardwalk Pipeline Partners
BWP
| $1.95M | 0.02% |
76,260
+2,450
| +3% | +$68.4K |
|
|
FDO
528
DELISTED
FAMILY DOLLAR STORES
FDO
| $1.95M | 0.02% |
29,954
-2,181
| -7% | -$149K |
|
529
CarMax
KMX
$8.42B
| $1.93M | 0.02% |
41,000
-200
| -0.5% | -$9.8K |
|
|
PARA
530
DELISTED
Paramount Global Class B
PARA
| $1.91M | 0.02% |
30,021
-2,372
| -7% | -$140K |
|
531
iShares Russell Mid-Cap Growth ETF
IWP
$19.6B
| $1.88M | 0.02% |
44,492
+22,152
| +99% | +$895K |
|
|
LIFE
532
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $1.86M | 0.02% |
24,607
-5,032
| -17% | -$380K |
|
533
Exelon
EXC
$48.9B
| $1.83M | 0.02% |
93,588
-87,004
| -48% | -$1.75M |
|
534
Transocean
RIG
$5.8B
| $1.81M | 0.02% |
36,691
| – | – |
|
535
ING
ING
$95.4B
| $1.8M | 0.02% |
128,933
+6,894
| +6% | +$87.9K |
|
536
Masco
MAS
$16.3B
| $1.8M | 0.02% |
90,180
+50,370
| +127% | +$937K |
|
537
Las Vegas Sands
LVS
$31.2B
| $1.79M | 0.02% |
22,749
-3,950
| -15% | -$284K |
|
538
Telephone and Data Systems
TDS
$3.92B
| $1.79M | 0.02% |
69,552
-3,842
| -5% | -$109K |
|
|
EQC
539
DELISTED
Equity Commonwealth
EQC
| $1.76M | 0.02% |
75,454
+31,484
| +72% | +$746K |
|
|
TOO
540
DELISTED
Teekay Offshore Partners L.P.
TOO
| $1.75M | 0.02% |
53,025
+525
| +1% | +$17.1K |
|
541
Huntington Bancshares
HBAN
$35B
| $1.75M | 0.02% |
180,921
+20,618
| +13% | +$185K |
|
542
State Street Energy Select Sector SPDR ETF
XLE
$39.1B
| $1.68M | 0.02% |
38,080
+230
| +0.6% | +$9.9K |
|
543
Philips
PHG
$26.1B
| $1.68M | 0.02% |
65,673
-513
| -0.8% | -$12.3K |
|
|
NSH
544
DELISTED
NuStar GP Holdings LLC
NSH
| $1.68M | 0.02% |
59,925
-5,475
| -8% | -$144K |
|
|
MWE
545
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $1.68M | 0.02% |
25,432
-3,809
| -13% | -$264K |
|
546
NGL Energy Partners
NGL
$1.92B
| $1.67M | 0.02% |
48,335
+1,350
| +3% | +$43K |
|
|
BRCM
547
DELISTED
BROADCOM CORP CL-A
BRCM
| $1.65M | 0.02% |
55,675
+38,743
| +229% | +$1.05M |
|
548
C.H. Robinson
CHRW
$20.9B
| $1.65M | 0.02% |
28,232
-15,137
| -35% | -$890K |
|
549
Mitsubishi UFJ Financial
MUFG
$260B
| $1.63M | 0.02% |
244,048
-41,202
| -14% | -$264K |
|
550
Conagra Brands
CAG
$7.27B
| $1.61M | 0.02% |
61,337
-99,478
| -62% | -$2.49M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q4 2013 Portfolio in Review
As of Q4 2013, Glenmede Trust held 2,579 positions worth $9.79B, up 16% from $8.42B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Glenmede Trust's Q4 2013 filing shows 256 new, 680 increased, 638 reduced and 183 closed positions. Its largest new stake was Korn Ferry: 518,057 shares worth $13.5M. The largest sale was Vanguard FTSE All-World ex-US ETF, an estimated $20.9M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.
- Glenmede Trust's largest Q4 2013 buy was Korn Ferry: 518,057 shares worth $13.5M.
- Glenmede Trust added most to Stryker in Q4 2013, an estimated $31.5M increase.
- Glenmede Trust's biggest Q4 2013 reduction was JPMorgan Chase, cutting an estimated $13.2M.
- Glenmede Trust fully exited Vanguard FTSE All-World ex-US ETF in Q4 2013, selling an estimated $20.9M.
- Glenmede Trust's ten largest holdings make up 16% of its $9.79B portfolio in Q4 2013.
- Glenmede Trust opened 256 new positions and closed 183 in Q4 2013.
- Glenmede Trust's portfolio value rose 16% quarter-over-quarter to $9.79B.
Based on Glenmede Trust's 13F filing for Q4 2013, filed 31 Jan 2014.